Blid et al.
F IGURE 3. NOE enhancement measurements of amines 10a ,b and 11. Mixing times were 700 (T1 ) 1.1 s), 600 (T1 ) 0.9 s), and
1250 ms (T1 ) 1.9 s) for 10a ,b and 11. G ) CON(CH2CH2)2.
SCHEME 4. Hg2+-Med ia ted Cycliza tion of th e
1-(2-Ben zyla m in o-1-oxo-4-p en ten yl)p yr r olid in e (3a ):
1H NMR (CDCl3, 400 MHz) δH 7.34-7.22 (m, 5H), 5.82 (ddt,
Secon d a r y Am in es syn -3b, a n ti-3b, a n d syn -3c
1H, J ) 17.1, 10.1, 7.1 Hz), 5.10 (d, 1H, J ) 17.1 Hz), 5.04 (d,
1H, J ) 10.1 Hz), 3.83 (d, 1H, J ) 13.1 Hz), 3.59 (d, 1H, J )
13.1 Hz), 3.54 (dt, 1H, J ) 12.2, 6.7 Hz), 3.45 (dt, 1H, J )
12.2, 6.9 Hz), 3.36 (t, 1H, J ) 6.8 Hz), 3.30 (dt, 1H, J ) 9.9,
6.7 Hz), 3.21 (dt, 1H, J ) 9.9, 6.6 Hz), 2.40-2.28 (m, 2H), 2.21
(bs, 1H), 1.92-1.80 (m, 4H); 13C NMR (CDCl3, 100 MHz) δC
172.7, 140.0, 134.4, 128.28, 128.26, 126.9, 117.3, 58.6, 51.8,
46.1 45.7, 37.9, 26.0, 24.1; IR (neat) 3316, 2973, 2876, 1637
cm-1; HRMS (EI+) calcd for C16H22N2O [M]+ 258.1732, found
258.1732.
(2R*,3R*)-1-(2-Ben zylam in o-3-m eth yl-1-oxo-4-pen ten yl)-
1
p yr r olid in e (a n ti-3b): H NMR (CDCl3, 500 MHz) δH 7.31
(m, 4H), 7.22 (m, 1H), 5.89 (ddd, 1H, J ) 17.6, 10.1, 7.2 Hz),
5.07 (d, 1H, J ) 17.6 Hz), 5.07 (d, 1H, J ) 10.1 Hz), 3.86 (d,
1H, J ) 13.6 Hz), 3.57 (d, 1H, J ) 13.6 Hz), 3.55 (m, 1H), 3.45
(m, 1H), 3.31 (m, 1H), 3.15 (d, 1H, J ) 7.2 Hz), 3.12 (m, 1H),
2.46 (sextet, 1H, J ) 7.2 Hz), 2.18 (bs, 1H), 1.89-1.78 (m, 4H),
1.02 (d, 3H, J ) 7.2 Hz); 13C NMR (CDCl3, 125 MHz) δC 172.6,
140.7, 140.3, 128.21, 128.17, 126.9, 114.9, 63.0, 51.9, 46.2, 45.6,
ment affording secondary amines 3 in good yields. (E)-
Crotyl- and (E)-cinnamylamine 2b and 2c displayed
excellent syn-diastereoselectivities in the rearrangement.
40.9, 26.1, 24.1, 16.7; IR (neat) 3327, 2971, 2875, 1632 cm-1
;
HRMS (CI+) calcd for C17H25N2O [M + H]+ 273.1967, found
273.1965.
DFT calculations on the deprotonated BF2+-1 and
BBr2+-1 complexes were in agreement with the experi-
mentally obtained diastereoselectivities, thereby provid-
ing a plausible reaction pathway for the BF3- and BBr3-
mediated [2,3]-sigmatropic rearrangement of allylic
R-amino amides.
(2R*,3S*)-1-(2-Ben zylam in o-3-ph en yl-1-oxo-4-pen ten yl)-
p yr r olid in e (syn -3c): H NMR (CDCl3, 400 MHz) δH 7.38-
1
7.17 (m, 10H), 6.17 (ddd, 1H, J ) 16.5, 9.7, 7.9 Hz), 5.12 (d,
1H, J ) 16.5 Hz), 5.09 (d, 1H, J ) 9.7 Hz), 3.81 (d, 1H, J )
13.4 Hz), 3.67 (t, 1H, J ) 7.9 Hz), 3.57 (d, 1H, J ) 13.4 Hz),
3.57 (d, 1H, J ) 7.9 Hz), 3.49 (m, 1H), 3.38 (m, 1H), 2.90 (m,
1H), 2.63 (m, 1H), 2.04 (bs, 1H), 1.72 (m, 3H), 1.59 (m, 1H);
13C NMR (CDCl3, 100 MHz) δC 171.4, 141,0, 139.8, 136.9,
128.4, 128.3, 128.2, 128.2, 126.9, 126.7, 117.4, 62.2, 54.0, 51.3,
46.0, 45.5., 25.9, 24.0; IR (neat) 3325, 3060, 3028, 2974, 2951,
1633 cm-1; HRMS (CI+) calcd for C22H27N2O [M + H]+
335.2123, found 335.2120.
Exp er im en ta l Section
Typ ica l P r oced u r e for th e Lew is Acid [2,3]-Sigm a tr o-
p ic Rea r r a n gem en t of Allylic Am in es 2. (2R*,3S*)-1-(2-
Ben zylam in o-3-m eth yl-1-oxo-4-pen ten yl)pyr r olidin e (syn -
3b). To a stirred solution of 2b (35 mg, 0.13 mmol) in toluene
(1.5 mL) at -78 °C was added BBr3 (1.0 m in hexanes; 0.15
mL, 0.15 mmol). To the resultant solution was added 6 (0.13
mmol), and the mixture was allowed to reach -20 °C. After
the mixture was stirred for 19 h at -20 °C, the reaction was
quenched by addition of H2O (1 mL) and allowed to stir for 1
h at rt. The solution was made alkaline with 2 M NaOH (1.5
mL) and the resultant mixture filtered through a prepacked
extraction tube, which was eluted with CH2Cl2 (15 mL). The
concentrated residue was chromatographed (MeCN/Et2O 0:1f1:
0) to provide syn-3b as a pale yellow oil (25 mg, 71%, ds >20:
1): 1H NMR (CDCl3, 500 MHz) δH 7.34 (d, 2H, J ) 7.1 Hz),
7.30 (t, 2H, J ) 7.1 Hz), 7.22 (t, 1H, J ) 7.1 Hz), 5.79 (ddd,
1H, J ) 17.2, 10.3, 7.3 Hz), 5.05 (d, 1H, J ) 17.2 Hz), 4.96 (d,
1H, J ) 10.3 Hz), 3.85 (d, 1H, J ) 13.4 Hz), 3.54 (d, 1H, J )
13.4 Hz), 3.54 (m, 1H,), 3.42 (dt, 1H, J ) 12.0, 6.6 Hz), 3.27
(m, 1H), 3.12 (m, 1H), 3.11 (d, 1H, J ) 7.3 Hz), 2.38 (sextet,
1H, J ) 7.3 Hz), 2.20 (bs, 1H), 1.88-1.77 (m, 4H), 1.12 (d, 3H,
J ) 7.3 Hz); 13C NMR (CDCl3, 125 MHz) δC 172.8, 140.7, 140.3,
128.22, 128.18, 126.8, 114.7, 63.1, 52.1, 46.2, 45.5, 41.4, 26.0,
24.2, 15.9; IR (neat) 3318, 2972, 2875, 1632 cm-1; HRMS (CI+)
calcd for C17H25N2O [M + H]+ 273.1967, found 273.1964.
(2R*,3R*)-1-(2-Ben zylam in o-3-ph en yl-1-oxo-4-pen ten yl)-
p yr r olid in e (a n ti-3c): 1H NMR (CDCl3, 500 MHz) δH 7.31
(m, 4H), 7.22 (m, 5H), 7.16 (m, 1H), 6.28 (ddd, 1H, J ) 17.2,
10.3, 8.3 Hz), 5.23 (d, 1H, J ) 17.2 Hz), 5.13 (d, 1H, J ) 10.3
Hz), 3.90 (d, 1H, J ) 13.6 Hz), 3.58 (d, 1H, J ) 13.6 Hz), 3.55
(t, 1H, J ) 8.3 Hz), 3.44 (d, 1H, J ) 9.5 Hz), 3.33 (m, 1H),
3.09 (m, 1H), 2.78 (m, 1H), 2.42 (m, 1H), 1.58 (m, 2H), 1.43
(m, 1H), 1.32 (m, 1H); 13C NMR (CDCl3, 125 MHz) δC 172.0,
141.2, 140.0, 138.4, 128.4, 128.24, 128.20, 128.1, 126.9, 126.7,
117.0, 63.4, 53.2, 51.8, 45.7, 45.2, 25.7, 23.8; IR (neat) 3311,
3049, 3029, 2970, 2873, 1633 cm-1; HRMS (CI+) calcd for
C
22H27N2O [M + H]+ 335.2123, found 335.2120.
1-(2-Ben zyla m in o-3,3-d im eth yl-1-oxo-4-p en ten yl)p yr -
r olid in e (3e): 1H NMR (CDCl3, 400 MHz) δH 7.30 (m, 4H),
7.22 (m, 1H), 5.95 (dd, 1H, J ) 17.5, 10.7 Hz), 5.01 (d, 1H, J
) 17.5 Hz), 4.99 (d, 1H, J ) 10.7 Hz), 3.85 (d, 1H, J ) 13.7
Hz), 3.54 (m, 1H), 3.52 (d, 1H, J ) 13.7 Hz), 3.40 (m, 1H),
3.25 (m, 1H), 3.01 (s, 1H), 2.99 (m, 1H), 2.09 (bs, 1H), 1.79 (m,
4H), 1.10 (s, 3H), 1.09 (s, 3H,); 13C NMR (CDCl3, 100 MHz) δC
172.5, 145.1, 140.4, 128.16, 128.15, 126.9, 112.2, 65.2, 52.1,
46.8, 45.4, 40.5, 26.1, 24.4, 24.2, 23.1; IR (neat) 3330, 3084,
3062, 2964, 2875, 1633 cm-1; HRMS (EI+) calcd for C18H27N2O
[M + H]+ 287.2123, found 287.2125.
3048 J . Org. Chem., Vol. 69, No. 9, 2004